Jason Kelly

2021

In 2021, Jason Kelly earned a total compensation of $380.7M as Chief Executive Officer at Ginkgo Bioworks Holdings, a 3,515% increase compared to previous year.

Compensation breakdown

Salary$250,000
Stock Awards$380,479,776
Other$12,500
Total$380,742,276

Kelly received $380.5M in stock awards, accounting for 100% of the total pay in 2021.

Kelly also received $250K in salary and $12.5K in other compensation.

Rankings

In 2021, Jason Kelly's compensation ranked 10th out of 12,388 executives tracked by ExecPay. In other words, Kelly earned more than 99.9% of executives.

ClassificationRankingPercentile
All
10
out of 12,388
100th
Division
Manufacturing
3
out of 5,492
100th
Major group
Chemicals And Allied Products
1
out of 2,367
100th
Industry group
Drugs
1
out of 2,090
100th
Industry
Biological Products, Except Diagnostic Substances
1
out of 452
100th
Source: SEC filing on April 26, 2022.

Kelly's colleagues

We found two more compensation records of executives who worked with Jason Kelly at Ginkgo Bioworks Holdings in 2021.

2021

Reshma Shetty

Ginkgo Bioworks Holdings

Chief Operating Officer

2021

Mark Dmytruk

Ginkgo Bioworks Holdings

Chief Financial Officer

News

You may also like